Publications
QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study.
Guglielmetti L, Tiberi S, Burman M, Kunst H, Wejse C, Togonidze T, Bothamley G, Lange C
TBNET, 16.08.2018
The European respiratory journal. 52, 2, pii1800537.
Clinical Management of Multidrug-resistant Tuberculosis in 16 European Countries
Gunar Günther, Frank van Leth, Sofia Alexandru, Neus Altet, Korkut Avsar, Didi Bang, Raisa Barbuta, Graham Bothamley, Ana Ciobanu, Valeriu Crudu, Manfred Danilovits,
Martin Dedicoat, Raquel Duarte, Gina Gualano, Heinke Kunst, Wiel de Lange, Vaira Leimane, Anne-Marie McLaughlin, Cecile Magis-Escurra, Inge Muylle, Veronika Polcová, Cristina Popa, Rudolf Rumetshofer, Alena Skrahina, Varvara Solodovnikova, Victor Spinu, Simon Tiberi, Piret Viiklepp, and Christoph Lange
TBNET, 01.08.2018,
American journal of respiratory and critical care medicine. 198, 3, S. 379-386 8 S.
A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study
Walker, T. M., Merker, M., Knoblauch, A. M., Helbling, P., Schoch, O. D., van der Werf, M. J., Kranzer, K., Fiebig, L., Kröger, S., Haas, W., Hoffmann, H., Indra, A., Egli, A., Cirillo, D. M., Robert, J., Rogers, T. R., Groenheit, R., Mengshoel, A. T., Mathys, V., Haanperä, M., Soolingen, D. V., Niemann, S., Böttger, E. C., Keller, P. M., MDR-TB Cluster Consortium & Lange, C., 04.2018
MDR-TB Cluster Consortium & Lange, C., 04.2018,
Lancet Infectious Diseases. 18, 4, S. 431-440 10 S.18, 4, S. 431-440 10 S.
10.1016/S1473-3099(18)30004-5
Clinical Management of Multidrug-resistant Tuberculosis in 16 European Countries.
Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M10, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Magis-Escurra C, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C; for TBNET.
Am J Respir Crit Care Med. 2018 Mar 6.
doi: 10.1164/rccm.201710-2141OC.
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement.
Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.
Zellweger JP, Sotgiu G, Block M, Dore S, Altet N, Blunschi R, Bogyi M, Bothamley G, Bothe C, Codecasa L, Costa P, Dominguez J, Duarte R, Fløe A, Fresard I, García-García JM, Goletti D, Halm P, Hellwig D, Henninger E, Heykes-Uden H, Horn L, Kruczak K, Latorre I, Pache G, Rath H, Ringshausen FC, Ruiz AS, Solovic I, Souza-Galvão ML, Widmer U, Witte P, Lange C; TBNET.
Am J Respir Crit Care Med. 2015 May 15;191(10):1176-84.
doi: 10.1164/rccm.201502-0232OC.
Risk Assessment of Tuberculosis in Immunocompromised Patients - A TBNET Study
Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Dilektasli AG, Domínguez J, Duarte R, Ernst M, Eyuboglu FO, Gerogianni I, Girardi E, Goletti D, Janssens JP, Julander I, Lange B, Latorre I, Losi M, Markova R, Matteelli A, Milburn H, Ravn P, Scholman T, Soccal PM, Straub M, Wagner D, Wolf T, Yalcin A, Lange C; TBNET.
Am J Respir Crit Care Med. 2014 Nov 15;190(10):1168-76.
doi: 10.1164/rccm.201405-0967OC.
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.
Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, Chang KC, Codecasa L, Correia A, Crudu V, Davies P, Dedicoat M, Drobniewski F, Duarte R, Ehlers C, Erkens C, Goletti D, Günther G, Ibraim E, Kampmann B, Kuksa L, de Lange W, van Leth F, van Lunzen J, Matteelli A, Menzies D, Monedero I, Richter E, Rüsch-Gerdes S, Sandgren A, Scardigli A, Skrahina A, Tortoli E, Volchenkov G, Wagner D, van der Werf MJ, Williams B, Yew WW, Zellweger JP, Cirillo DM; TBNET.
Eur Respir J. 2014 Jul;44(1):23-63.
doi: 10.1183/09031936.00188313. Epub 2014 Mar 23.
Multidrug-resistant tuberculosis in Europe, 2010-2011
Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Pontali E, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C; TBNET.
Emerg Infect Dis. 2015 Mar;21(3):409-16.
doi: 10.3201/eid2103.141343.
Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure
Treatment outcomes of MDR-TB and HIV co-infection in Europe.
Magis-Escurra C, Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Muylle I, Polcová V,Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBnet.
Eur Respir J. 2017 Jun 8;49(6). pii: 1602363.
doi: 10.1183/13993003.02363-2016. Print 2017 Jun. PubMed PMID: 28596434.
Treatment Outcomes in Multidrug-Resistant Tuberculosis
Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBNET.
N Engl J Med. 2016 Sep 15;375(11):1103-5.
doi: 10.1056/NEJMc1603274. PubMed PMID: 27626539.